Initial Treatment for Hyperthyroidism
The initial treatment for hyperthyroidism is methimazole (antithyroid medication), with beta-blockers added for symptomatic patients. 1, 2
Diagnosis Confirmation
Before initiating treatment, confirm hyperthyroidism with:
- Low TSH and elevated free T4 and/or free T3 levels
- Determine etiology (Graves' disease, toxic nodular goiter, thyroiditis)
- Consider TSH-receptor antibodies, thyroid peroxidase antibodies, ultrasound, or scintigraphy if etiology is unclear 3
Treatment Algorithm
First-Line Therapy
Antithyroid Medication (Methimazole)
Symptomatic Management with Beta-Blockers
- For patients with symptoms (tachycardia, tremor, anxiety)
- Options include propranolol or atenolol/metoprolol 2
- Continue until symptoms resolve
Special Considerations
Pregnancy:
- Propylthiouracil is preferred in first trimester due to lower risk of birth defects
- Switch to methimazole for second and third trimesters 1
- Use lowest effective dose
Breastfeeding:
- Methimazole is compatible with breastfeeding 1
- Monitor infant's thyroid function
Children:
- Methimazole is preferred over propylthiouracil due to lower risk of severe liver injury 1
Monitoring and Follow-up
- Check thyroid function tests (TSH, free T4, free T3) every 4-6 weeks until stable
- Monitor for side effects:
- Agranulocytosis (sore throat, fever, infection)
- Hepatotoxicity
- Skin rashes
- Vasculitis
- Adjust dose based on clinical response and lab values
- Maintenance dose typically 5-10 mg daily 4
Treatment Duration and Alternatives
- Standard course: 12-18 months of antithyroid drugs 4
- Recurrence rate after discontinuation: approximately 50% 3
- Alternative treatments if antithyroid drugs fail or are contraindicated:
Important Caveats
- Patients should be educated about potential side effects and instructed to report immediately any signs of infection, rash, jaundice, or unusual bleeding
- Methimazole may interact with anticoagulants, beta-blockers, digitalis, and theophylline; dose adjustments may be needed 1
- For thyroiditis-induced hyperthyroidism, which is self-limiting, supportive care with beta-blockers may be sufficient without antithyroid drugs 2
By following this treatment approach, most patients will achieve euthyroidism within 14-17 weeks 5, significantly reducing the risk of complications such as cardiac arrhythmias, heart failure, osteoporosis, and adverse pregnancy outcomes 7.